Literature DB >> 34249460

Deletion of Foxa1 in the mouse mammary gland results in abnormal accumulation of luminal progenitor cells: a link between reproductive factors and ER-/TNBC breast cancer?

Sirinapa Sribenja1, Orla Maguire2, Kristopher Attwood3, Matthew F Buas4, Julie R Palmer5, Christine B Ambrosone4, Michael J Higgins1.   

Abstract

In humans, parity without breastfeeding increases risk of estrogen receptor-negative (ER-) breast cancer and is associated with hypermethylation of FOXA1, a pioneer factor regulating lineage commitment of mammary gland luminal progenitor cells. We postulate that pregnancy-associated repression of FOXA1 results in the accumulation of aberrant, differentiation-arrested luminal progenitor cells which, following additional genetic and epigenetic insults, may give rise to ER- tumors. Consistent with this hypothesis, we show that deletion of Foxa1 in the mouse mammary gland results in a two-fold increase in the proportion of luminal progenitor cells and a reduction in mammary gland epithelial cells that stain positive for ER. These results provide compelling support for the notion that reduced Foxa1 expression is sufficient to alter mammary gland luminal cell fate determination in vivo, which could be a mechanism linking parity with ER- breast cancer. AJCR
Copyright © 2021.

Entities:  

Keywords:  Foxa1; breastfeeding; mammary gland; pregnancy; progenitors

Year:  2021        PMID: 34249460      PMCID: PMC8263678     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  25 in total

1.  FOXA1 Protein Expression in ER+ and ER- Breast Cancer in Relation to Parity and Breastfeeding in Black and White Women.

Authors:  Ting-Yuan David Cheng; Song Yao; Angela R Omilian; Thaer Khoury; Matthew F Buas; Rochelle Payne-Ondracek; Sirinapa Sribenja; Wiam Bshara; Chi-Chen Hong; Elisa V Bandera; Warren Davis; Michael J Higgins; Christine B Ambrosone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-12-23       Impact factor: 4.254

2.  Stem Cells and the Differentiation Hierarchy in Mammary Gland Development.

Authors:  Nai Yang Fu; Emma Nolan; Geoffrey J Lindeman; Jane E Visvader
Journal:  Physiol Rev       Date:  2019-09-20       Impact factor: 37.312

3.  FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women?

Authors:  Allyson C Espinal; Matthew F Buas; Dan Wang; David Ting-Yuan Cheng; Lara Sucheston-Campbell; Qiang Hu; Li Yan; Rochelle Payne-Ondracek; Eduardo Cortes; Li Tang; Zhihong Gong; Gary Zirpoli; Thaer Khoury; Song Yao; Angela Omilian; Kitaw Demissie; Elisa V Bandera; Song Liu; Christine B Ambrosone; Michael J Higgins
Journal:  Breast Cancer Res Treat       Date:  2017-07-29       Impact factor: 4.872

4.  Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1.

Authors:  Sagar Ghosh; Fei Gu; Chou-Miin Wang; Chun-Lin Lin; Joseph Liu; Howard Wang; Peter Ravdin; Yanfen Hu; Tim H M Huang; Rong Li
Journal:  Breast Cancer Res Treat       Date:  2014-09-19       Impact factor: 4.872

5.  FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer.

Authors:  C Gong; K Fujino; L J Monteiro; A R Gomes; R Drost; H Davidson-Smith; S Takeda; U S Khoo; J Jonkers; D Sproul; E W-F Lam
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

6.  Differentiation dynamics of mammary epithelial cells revealed by single-cell RNA sequencing.

Authors:  Karsten Bach; Sara Pensa; Marta Grzelak; James Hadfield; David J Adams; John C Marioni; Walid T Khaled
Journal:  Nat Commun       Date:  2017-12-11       Impact factor: 14.919

7.  Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry.

Authors:  Christine B Ambrosone; Allyson C Young; Lara E Sucheston; Dan Wang; Li Yan; Song Liu; Li Tang; Qiang Hu; Jo L Freudenheim; Peter G Shields; Carl D Morrison; Kitaw Demissie; Michael J Higgins
Journal:  Oncotarget       Date:  2014-01-15

8.  Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.

Authors:  Mona Shehata; Andrew Teschendorff; Gemma Sharp; Nikola Novcic; I Alasdair Russell; Stefanie Avril; Michael Prater; Peter Eirew; Carlos Caldas; Christine J Watson; John Stingl
Journal:  Breast Cancer Res       Date:  2012-10-22       Impact factor: 6.466

9.  Cell Fate Decisions During Breast Cancer Development.

Authors:  Kayla Gross; Ania Wronski; Adam Skibinski; Sarah Phillips; Charlotte Kuperwasser
Journal:  J Dev Biol       Date:  2016-01-22

10.  Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development.

Authors:  Rajshekhar R Giraddi; Chi-Yeh Chung; Richard E Heinz; Ozlen Balcioglu; Mark Novotny; Christy L Trejo; Christopher Dravis; Berhane M Hagos; Elnaz Mirzaei Mehrabad; Luo Wei Rodewald; Jae Y Hwang; Cheng Fan; Roger Lasken; Katherine E Varley; Charles M Perou; Geoffrey M Wahl; Benjamin T Spike
Journal:  Cell Rep       Date:  2018-08-07       Impact factor: 9.423

View more
  2 in total

1.  Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting.

Authors:  Song Yao; Peter T Campbell; Tomotaka Ugai; Gretchen Gierach; Montserrat Garcia-Closas; Timothy R Rebbeck; Christine B Ambrosone; Shuji Ogino; Mustapha Abubakar; Viktor Adalsteinsson; Jonas Almeida; Paul Brennan; Stephen Chanock; Todd Golub; Samir Hanash; Curtis Harris; Cassandra A Hathaway; Karl Kelsey; Maria Teresa Landi; Faisal Mahmood; Christina Newton; John Quackenbush; Scott Rodig; Nikolaus Schultz; Guillermo Tearney; Shelley S Tworoger; Molin Wang; Xuehong Zhang
Journal:  Cancer Causes Control       Date:  2022-06-27       Impact factor: 2.532

2.  FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact.

Authors:  Jasna Metovic; Fulvio Borella; Marta D'Alonzo; Nicoletta Biglia; Luca Mangherini; Cristian Tampieri; Luca Bertero; Paola Cassoni; Isabella Castellano
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.